TY - JOUR
T1 - New insights into the mechanisms of high-fat diet mediated gut microbiota in chronic diseases
AU - Chen, Jiali
AU - Xiao, Yuhang
AU - Li, Dongmei
AU - Zhang, Shiqing
AU - Wu, Yingzi
AU - Zhang, Qing
AU - Bai, Weibin
N1 - National Natural Science Foundation of China, Grant/Award Numbers: 32101933, 32172220, U22A20546; Youth Science and Technology Innovation Talent of Guangdong TeZhi Plan, Grant/Award Number: 2019TQ05N770.
Publisher Copyright:
© 2023 The Authors. iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.
PY - 2023/2
Y1 - 2023/2
N2 - High-fat diet (HFD) has been recognized as a primary factor in the risk of chronic disease. Obesity, diabetes, gastrointestinal diseases, neurodegenerative diseases, and cardiovascular diseases have long been known as chronic diseases with high worldwide incidence. In this review, the influences of gut microbiota and their corresponding bacterial metabolites on the mechanisms of HFD-induced chronic diseases are systematically summarized. Gut microbiota imbalance is also known to increase susceptibility to diseases. Several studies have proven that HFD has a negative impact on gut microbiota, also exacerbating the course of many chronic diseases through increased populations of Erysipelotrichaceae, facultative anaerobic bacteria, and opportunistic pathogens. Since bile acids, lipopolysaccharide, short-chain fatty acids, and trimethylamine N-oxide have long been known as common features of bacterial metabolites, we will explore the possibility of synergistic mechanisms among those metabolites and gut microbiota in the context of HFD-induced chronic diseases. Recent literature concerning the mechanistic actions of HFD-mediated gut microbiota have been collected from PubMed, Google Scholar, and Scopus. The aim of this review is to provide new insights into those mechanisms and to point out the potential biomarkers of HFD-mediated gut microbiota.
AB - High-fat diet (HFD) has been recognized as a primary factor in the risk of chronic disease. Obesity, diabetes, gastrointestinal diseases, neurodegenerative diseases, and cardiovascular diseases have long been known as chronic diseases with high worldwide incidence. In this review, the influences of gut microbiota and their corresponding bacterial metabolites on the mechanisms of HFD-induced chronic diseases are systematically summarized. Gut microbiota imbalance is also known to increase susceptibility to diseases. Several studies have proven that HFD has a negative impact on gut microbiota, also exacerbating the course of many chronic diseases through increased populations of Erysipelotrichaceae, facultative anaerobic bacteria, and opportunistic pathogens. Since bile acids, lipopolysaccharide, short-chain fatty acids, and trimethylamine N-oxide have long been known as common features of bacterial metabolites, we will explore the possibility of synergistic mechanisms among those metabolites and gut microbiota in the context of HFD-induced chronic diseases. Recent literature concerning the mechanistic actions of HFD-mediated gut microbiota have been collected from PubMed, Google Scholar, and Scopus. The aim of this review is to provide new insights into those mechanisms and to point out the potential biomarkers of HFD-mediated gut microbiota.
KW - characteristic metabolites
KW - chronic diseases
KW - gut microbiota dysbiosis
KW - high-fat diet
KW - targeted biomarkers
UR - http://www.scopus.com/inward/record.url?scp=85148576621&partnerID=8YFLogxK
UR - https://onlinelibrary.wiley.com/doi/10.1002/imt2.69
U2 - 10.1002/imt2.69
DO - 10.1002/imt2.69
M3 - Journal article
AN - SCOPUS:85148576621
SN - 2770-5986
VL - 2
JO - iMeta
JF - iMeta
IS - 1
M1 - e69
ER -